Ken Griffin
JAGX icon

Ken Griffin’s Jaguar Health JAGX Stock Holding History

Ken Griffin’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$29.3K – 15032
2023
Q4 		$29.3K Buy
+4
New +$54.7K ﹤0.01% 12286
2023
Q3 		– Hold
0
– -$8.01K – 14703
2023
Q2 		– Hold
0
– – – 13344
2023
Q1 		– Hold
0
– -$87.1K – 15101
2022
Q4 		– Hold
0
– – – 11405
2022
Q2 		– Hold
0
– – – 13494
2022
Q1 		– Hold
0
– – – 11822
2021
Q4 		– Hold
0
– – – 13027
2021
Q3 		– Hold
0
– – – 12261
2021
Q2 		– Hold
0
– – – 13546
2021
Q1 		– Hold
0
– – – 12013
2020
Q4 		– Hold
0
– -$111K – 11223
2020
Q3 		– Hold
0
– – – 9215
2020
Q2 		– Hold
0
– – – 9612
2019
Q1 		– Hold
0
– -$3K – 9587
2018
Q4 		– Hold
0
– – – 8996
2018
Q3 		– Hold
0
– – – 8864
2018
Q2 		– Hold
0
– -$8K – 9062
2018
Q1 		– Hold
0
– – – 8186
2017
Q4 		– Hold
0
– – – 7724

Other funds holding JAGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Ken Griffin's JAGX Position: Q1 2024 in Review

Ken Griffin sold out of Jaguar Health (JAGX) in Q1 2024, closing a stake of 4 shares — an estimated $29.3K sold.

Ken Griffin first reported a position in JAGX in Q4 2023 and held it in 1 quarter. The position peaked at $29.3K in Q4 2023. 14 funds tracked by Wall St. Rank hold JAGX as of Q1 2024.

  • Ken Griffin reported no remaining Jaguar Health position as of Q1 2024 after selling out during the quarter.
  • Ken Griffin sold 4 Jaguar Health shares in Q1 2024, an estimated $29.3K.
  • Ken Griffin first reported a position in Jaguar Health in Q4 2023 and held it in 1 quarter.
  • Ken Griffin's Jaguar Health position peaked at $29.3K in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.